Sens. Pitch Bill To Streamline Research Into Schedule I Drugs
Two U.S. senators unveiled a bipartisan bill Thursday that would amend the Controlled Substances Act to expedite research into potential medical uses of Schedule I substances, such as MDMA and psilocybin....To view the full article, register now.
Already a subscriber? Click here to view full article